BCTX
Price
$3.44
Change
+$0.10 (+2.99%)
Updated
Jun 6 closing price
Capitalization
23.33M
PTCHF
Price
$1.68
Change
+$0.03 (+1.82%)
Updated
May 15 closing price
Capitalization
455.02M
Interact to see
Advertisement

BCTX vs PTCHF

Header iconBCTX vs PTCHF Comparison
Open Charts BCTX vs PTCHFBanner chart's image
Briacell Therapeutics Corp NEW
Price$3.44
Change+$0.10 (+2.99%)
Volume$89.63K
Capitalization23.33M
PureTech Health
Price$1.68
Change+$0.03 (+1.82%)
Volume$585
Capitalization455.02M
BCTX vs PTCHF Comparison Chart
Loading...
BCTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BCTX vs. PTCHF commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCTX is a Hold and PTCHF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (BCTX: $3.44 vs. PTCHF: $1.68)
Brand notoriety: BCTX and PTCHF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCTX: 5% vs. PTCHF: 20%
Market capitalization -- BCTX: $23.33M vs. PTCHF: $455.02M
BCTX [@Biotechnology] is valued at $23.33M. PTCHF’s [@Biotechnology] market capitalization is $455.02M. The market cap for tickers in the [@Biotechnology] industry ranges from $324.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCTX’s FA Score shows that 1 FA rating(s) are green whilePTCHF’s FA Score has 0 green FA rating(s).

  • BCTX’s FA Score: 1 green, 4 red.
  • PTCHF’s FA Score: 0 green, 5 red.
According to our system of comparison, BCTX is a better buy in the long-term than PTCHF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCTX’s TA Score shows that 3 TA indicator(s) are bullish.

  • BCTX’s TA Score: 3 bullish, 6 bearish.

Price Growth

BCTX (@Biotechnology) experienced а 0.00% price change this week, while PTCHF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.04%. For the same industry, the average monthly price growth was +14.90%, and the average quarterly price growth was +1.90%.

Reported Earning Dates

BCTX is expected to report earnings on Mar 12, 2025.

Industries' Descriptions

@Biotechnology (+9.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PTCHF($455M) has a higher market cap than BCTX($23.3M). PTCHF YTD gains are higher at: -16.000 vs. BCTX (-59.410). BCTX has higher annual earnings (EBITDA): -27.19M vs. PTCHF (-53.65M). PTCHF has more cash in the bank: 502M vs. BCTX (5.01M). BCTX has less debt than PTCHF: BCTX (27K) vs PTCHF (24M). BCTX (0) and PTCHF (0) have equivalent revenues.
BCTXPTCHFBCTX / PTCHF
Capitalization23.3M455M5%
EBITDA-27.19M-53.65M51%
Gain YTD-59.410-16.000371%
P/E RatioN/A8.00-
Revenue00-
Total Cash5.01M502M1%
Total Debt27K24M0%
FUNDAMENTALS RATINGS
BCTX vs PTCHF: Fundamental Ratings
BCTX
PTCHF
OUTLOOK RATING
1..100
245
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
53
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9992
PRICE GROWTH RATING
1..100
9163
P/E GROWTH RATING
1..100
151
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PTCHF's Valuation (53) in the null industry is somewhat better than the same rating for BCTX (96). This means that PTCHF’s stock grew somewhat faster than BCTX’s over the last 12 months.

PTCHF's Profit vs Risk Rating (100) in the null industry is in the same range as BCTX (100). This means that PTCHF’s stock grew similarly to BCTX’s over the last 12 months.

PTCHF's SMR Rating (92) in the null industry is in the same range as BCTX (99). This means that PTCHF’s stock grew similarly to BCTX’s over the last 12 months.

PTCHF's Price Growth Rating (63) in the null industry is in the same range as BCTX (91). This means that PTCHF’s stock grew similarly to BCTX’s over the last 12 months.

BCTX's P/E Growth Rating (1) in the null industry is somewhat better than the same rating for PTCHF (51). This means that BCTX’s stock grew somewhat faster than PTCHF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BCTX
RSI
ODDS (%)
Bullish Trend 2 days ago
67%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
87%
Momentum
ODDS (%)
Bearish Trend 2 days ago
80%
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 2 days ago
80%
Declines
ODDS (%)
Bearish Trend 4 days ago
83%
BollingerBands
ODDS (%)
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
BCTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OCSL14.330.23
+1.63%
Oaktree Specialty Lending Corp
PRE8.320.11
+1.40%
Prenetics Global Limited
GXO42.210.28
+0.67%
GXO Logistics
CP81.900.04
+0.05%
Canadian Pacific Kansas City Limited
VIGL7.88N/A
N/A
Vigil Neuroscience

BCTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCTX has been loosely correlated with SNPX. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if BCTX jumps, then SNPX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCTX
1D Price
Change %
BCTX100%
+2.99%
SNPX - BCTX
35%
Loosely correlated
-10.41%
KROS - BCTX
33%
Poorly correlated
-0.46%
MDGL - BCTX
30%
Poorly correlated
+1.51%
AXON - BCTX
30%
Poorly correlated
+1.52%
LSB - BCTX
30%
Poorly correlated
+0.10%
More

PTCHF and

Correlation & Price change

A.I.dvisor tells us that PTCHF and KURA have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PTCHF and KURA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PTCHF
1D Price
Change %
PTCHF100%
N/A
KURA - PTCHF
30%
Poorly correlated
+2.44%
PRTC - PTCHF
30%
Poorly correlated
+2.15%
STTK - PTCHF
24%
Poorly correlated
+7.55%
LYEL - PTCHF
23%
Poorly correlated
+11.34%
BCTX - PTCHF
22%
Poorly correlated
+2.99%
More